Histone H4 抗体 (acLys5)
Our Local Distributor
北京 101111
Quick Overview for Histone H4 抗体 (acLys5) (ABIN2668876)
抗原
See all Histone H4 (HISTH4) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- acLys5
-
纯化方法
- None
-
免疫原
- This Histone H4 acetylLys5 antibody was raised against a peptide including acetyllysine 5 of histone H4.
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
-
Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
-
储存条件
- -20 °C
-
储存方法
- Antibodies in solution can be stored at -20 °C for 2 years.
-
有效期
- 6 months
-
-
-
: "Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators." in: Experimental hematology, Vol. 43, Issue 6, pp. 448-61.e2, (2015) (PubMed).
: "Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes." in: Diabetes, Vol. 63, Issue 5, pp. 1748-62, (2014) (PubMed).
: "Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression." in: PLoS ONE, Vol. 7, Issue 2, pp. e31573, (2012) (PubMed).
: "Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines." in: Leukemia & lymphoma, Vol. 53, Issue 5, pp. 973-81, (2012) (PubMed).
-
: "Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators." in: Experimental hematology, Vol. 43, Issue 6, pp. 448-61.e2, (2015) (PubMed).
-
- Histone H4 (HISTH4)
-
别名
- Histone H4
-
分子量
- 8 kDa
-
基因ID
- 121504
抗原
-